RFP - Environmental Assessment Study of Central Medical Stores and Identified Kabul Hospitals
Health Partners International of Canada
Location: Afghanistan
Last Date: September 15, 2010
Environmental Assessment Study of Central Medical Stores and
Identified Kabul Hospitals
Request for Proposals
Capacity Building and Access to Medicines (CBAM) Afghanistan
Location: Kabul, Afghanistan
A.
Introduction
The goal of the Capacity Building and Access to Medicines (CBAM)
project is to support the Ministry of Public Health (MoPH) of Afghanistan to
effectively ensure greater and more equitable access to priority pharmaceuticals
and medical supplies for all Afghans with a specific emphasis on women and
children. It is essential that environmental issues are considered throughout
the implementation of the CBAM project, therefore Health Partners International
of Canada (HPIC), as the implementing partner of the CBAM project, has agreed to
conduct an Environmental Assessment Study (EAS) of the MoPH Central Medical
Stores (CMS) and identified public hospitals in Kabul. The goal of the study is
to identify current environmental procedures, methods to improve environmental
systems and encourage environmental best-practices for the handling,
distribution and disposal of pharmaceutical products.
CURRENTLY HPIC IS CONDUCTING A PROJECT TO BUILD NATIONAL HEALTH SECTOR
CAPACITIES IN AFGHANISTAN AND IS SEEKING A CONSULTANT TO SUBMIT A FULL PROPOSAL
TO CONDUCT AN ENVIRONMENTAL ASSESSMENT STUDY OF THE CMS AND IDENTIFIED PARTNER
HOSPITALS TO BE PART OF THE CAPACITY BUILDING AND ACCESS TO MEDICINE (CBAM)
PROJECT.
Details
follow:
The CMS, operating under the MoPH General Directorate of
Administrative Affairs (GDAA), is an integral part of the pharmaceutical
distribution system in Afghanistan as the national warehouse that stores and
manages pharmaceuticals and medical supplies for public health facilities. The
CMS is a complex storage and distribution facility that must function under
certain standards to appropriately manage the national stocks of pharmaceutical
and medical supplies in conjunction with the public hospitals of Afghanistan.
Storing and distributing pharmaceuticals and medical supplies can be
challenging, especially in Afghanistan as the CMS and hospitals have been
neglected and are daily faced with the realities of limited resources and
complex management systems. In addition, the CMS has become a receptacle for
unwanted, returned, unused, damaged and expired medical supplies and
pharmaceuticals (hereafter referred to as waste products); many of which are
returned from MoPH health facilities, including public hospitals. Therefore, the
CMS was identified as a critical component of pharmaceutical management and as
such environmental considerations and concerns take priority.
A second component of the EAS will include working with CBAM
project partner hospitals in Kabul to increase their awareness of environmental
issues to reduce and properly manage waste pharmaceuticals and supplies handled
at the hospitals and filtered through the CMS. The goal of working with
identified public hospitals is part of wider efforts to improve environmental
considerations and provide environmental awareness consultations and training in
waste management at the hospital level. As a result of the EAS, environmental
issues can be addressed with the goal of improving waste management throughout
MoPH facilities directly involved with the management and disposal of
pharmaceutical products.
There will be a special focus on the disposal of waste
pharmaceuticals and medical supplies at the CMS, since it has become a storage
place for waste products. Recommendations for standard operating procedures
(SOPs) dealing specifically with disposal will be essential. The goal is for the
SOP recommendations stemming from the environmental assessment to be of
internationally acceptable standards in order to improve the overall functioning
standards of the facility. The study will also require close collaboration with
the CMS management and staff, as well as representatives of various branches of
the MoPH. The entire EAS is to begin in October 2010 and be concluded by
December 2010, which includes preparation, in country assessment, interpretation
of results, presentation of preliminary findings to CMS, drafting a final report
and presenting the findings to HPIC.
B.
QUALIFICATIONS OF CONSULTANTS
-
Education: Master’s degree or higher
-
Work Experience: 10 years
or more
-
Expertise: International experience in environmental standards
for pharmaceutical warehouses and hospitals pharmacies
C.
DELIVERABLES
The deliverables of the assignment shall include:
a.
Assessment framework and tools
b.
Presentation to stakeholders of preliminary findings of
assessment
c.
Preliminary report to HPIC
d.
Final Environment Assessment Study Report
i.
Recommendations for environmental SOPs
ii.
Recommendations for trainings and equipment to aid in
implementation of environmental best practices both at the CMS and identified
public hospitals in Kabul.
D.
DEADLINES
Due dates for various activity components:
a.
PROPOSAL MUST BE SUBMITTED TO HPIC BY
SEPTEMBER 15, 2010 BY 5:00PM EST at
knicholson@hpicafghanistan.ca.
Only complete proposals based on this RFP will be evaluated.
b.
Preparation, including assessment framework and tools, to be
complete by October 31, 2010
c.
Field-based information gathering to be complete by November 30,
2010
d.
Meeting to present preliminary findings to stakeholders to be
complete by November 30, 2010
e.
Final assessment report including recommendations to be complete
by December 22, 2010
E.
TIMEFRAMES
Gathering information for the assessment study will begin in
October 2010 and be completed by November 2010. The stakeholders meeting to
present preliminary findings of the study will be held once all data has been
collected. The final assessment report is to be submitted no later than December
22, 2010.
F.
RATIONALE FOR ASSIGNMENT
Due to decades of war, the environment in Afghanistan has been
severely neglected. There has been drought, desertification and contamination of
water and soil throughout the country. These environmental issues only
exacerbate the already poor health conditions that people face in Afghanistan.
Although many improvements have been made to give people access to better health
care, all of that can be undermined through environmental issues, contamination
and disasters. According to a 2009 United Nation’s Environmental Program (UNEP)
report “medical waste…is a serious threat”
to the health of the Afghan population as it can make its way into water
supplies and contaminate soil. The Government of Afghanistan (GoA) and
particularly the MoPH are responsible for a large amount of pharmaceuticals that
enter the country and how these items travel through the supply chain to the
patients or, when necessary, to disposal. The CMS and hospitals are a crucial
step in the pharmaceutical supply chain and thus contribute to the way that
medical and pharmaceutical waste are dealt with in the country.
The years of war have caused serious damage to infrastructure and
have reduced the capacities of many facilities. The CMS is no exception.
Although it is still a functional facility, there are challenges with proper
electricity, storage and temperature control, among others. With the current
rebuilding efforts in Afghanistan it is essential to establish proper controls
for pharmaceutical waste management at the CMS in order to move forward towards
building international environmental standards in pharmaceutical management.
Therefore, the CMS requires solutions to address the above mentioned problems
that may include recommendations for proper pharmaceutical disposal and
environmental best practices, new equipment and supplies, trainings, etc. It is
expected that the solutions required will be included in the final report of the
environmental assessment study. In addition, the hospitals will require
recommendations for SOPs as well as training on internationally recognized best
practices and environment and waste management in a hospital setting which will
also be the output of the commissioned study.
Anticipated Activities of the Environmental Assessment Study
The nature of handling pharmaceutical products requires all
materials to be handled in an environmentally safe manner to protect the
employees that work in hospitals and the CMS, as well as to protect
Afghanistan’s environment from becoming contaminated by pharmaceutical products
and wastes. The assessment study will require special emphasis on waste
management at the CMS and hospitals and disposal methods that are suitable to
Afghanistan and existing facilities within the country. Methods to be explored
can include, but are not limited to:
-
Incineration of waste pharmaceuticals and medical supplies,
including open container, medium temperature and high temperature incineration
-
Recycling of supplies and equipment
-
Landfills, including highly engineered sanitary landfills,
engineered landfills and open uncontrolled non-engineered dumps
-
Waste immobilization, including encapsulation and inertization
-
Water drainage disposal methods
-
Chemical decomposition
-
Others
Currently, landfills and incineration are common methods for
disposing medical waste in Afghanistan. However, incineration is often done in
the open air which creates a major public air quality health concern for
communities in the area. Considering this, alternate and innovative disposal
methods will be explored as part of the assessment study. Furthermore, a cost
effectiveness analysis will be conducted to compare the appropriateness of
various methods of waste disposal for the CMS. Currently many of the waste
pharmaceuticals, supplies and equipment remain at the CMS and it is necessary to
find economical and environmentally conscientious methods of disposal so that
space can be better utilized and that the work environment can be sanitary and
safe.
Further, the assessment study will also examine environmental
practices at the CMS and provide recommendations for standard operating
procedures (SOPs), specifically targeting environmentally safe handling, storing
and distributing. Recommendations for SOPs dealing specifically with disposal
will be essential. The goal is for the SOP recommendations stemming from the
environmental assessment to be of internationally acceptable standards in order
to improve the overall functioning standards of the facility.
In working with the hospitals, environmental best practices will
be encouraged to reduce waste that is returned to the CMS and build their
capacity to manage pharmaceuticals in an environmentally conscientious manner.
Involvement at identified hospitals will also include recommendations for
trainings and development of SOPs that can have an immediate impact at the
hospital level. The goal is for involvement at the identified hospitals to be
complementary to the study’s involvement and activities at the CMS, thereby
affecting a larger impact on components of pharmaceutical waste management.
The assessment study report will identify trainings for the CMS
staff and directors as well as the hospital staff and management to increase
their knowledge of environmental issues in supply chain logistics, warehouse
management, pharmacy management and hospital best practices. This will
contribute to the sustainability of environmental SOPs that are being
implemented and ultimately will contribute to the sustainability of
environmental consciousness at the CMS and hospitals. Finally, the assessment
study will include the review of current dumping sites and incineration fields
that surround Kabul considering major public health concerns of the residing
populations.
The study requires close collaboration with the CMS management
and staff, as well as representatives of various branches of the MoPH. Their
participation is important in determining viable and sustainable solutions to
waste management issues. The result of their input will be recommendations for
SOPs that can be effectively implemented at the CMS and consultations at the
hospitals to guide them towards best practices. The study will also require the
consultant to interact with hospital pharmacy staff and directors at two or
three identified hospitals to provide consultation on internationally recognized
environmental best practices in a hospital setting.
G.
GOAL AND OBJECTIVES
Goal:
The goal of the CMS and hospital EAS is to identify feasible
areas of intervention to increase the use of environmental best practices and to
identify waste management procedures to be implemented at the CMS and identified
partner hospitals in Kabul. There will be a special emphasis on appropriate
disposal of waste pharmaceuticals and medical supplies that are relevant and can
be integrated into the management of the CMS and hospitals. The consultant will
be required to observe daily activities and examine current operations and
manuals, in comparison to international standards. The assessment will determine
the steps that can be taken to have the greatest impact in hospitals and at the
CMS based on the needs of the staff, management and the MoPH to build their
capacity to conduct activities in an environmentally conscientious manner.
Objectives:
1.
Conduct review of relevant documents, research and other sources
of information pertaining to the CMS and hospitals. This will also include
relevant regional information, international guidelines and pertinent literature
on environmental warehouse management and logistics as well as environmental
best practices in a hospital setting. A summary of this literature review will
be included in the final report. Conduct a thorough environmental assessment
study of the CMS and a minor assessment of two or three identified public
hospitals in Kabul, including the following (others to be identified through the
assessment process):
a.
A physical assessment of current CMS facilities and identified
hospitals
b.
An assessment of current operating procedures at the CMS and
identified public hospitals that pertain to the environment, including
pharmaceutical and medical supply waste management
c.
Visit and examine local waste disposal facilities for
appropriateness of disposing pharmaceutical waste products
d.
Identify regional expertise (if possible)
e.
Identify relevant and feasible strategies for pharmaceutical
waste disposal for the CMS and identified hospitals
f.
Determine training and equipment needs for CMS and hospital staff
as it relates to environmental issues
2.
Compile data into a report to demonstrate how the CMS can improve
their environmental practices through SOPs, trainings, equipment and waste
management policies and how the hospitals can improve their SOPs and
environmental practices.
H.
APPROACH AND METHODOLOGY
1.
Parties Involved:
During the assignment, work and collaboration will occur between the following:
a.
Evaluation Team: HPIC anticipates engaging a core team of
approximately 2 international expert consultants along with up to 2 local expert
consultants (given time and space constraints and considerations). The team
should include individuals with expertise covering at least the following areas:
i.
Pharmaceutical waste management in developing countries (or
middle and low income countries) or resource limited regions
ii.
Warehouse and logistics operations
iii.
Environmental Specialist in international development familiar
with warehouse operations and hospital management
iv.
Experience in hospital environmental management.
b.
Stakeholders Team: individuals and organizations who will
participate in the assessment as participants, informants and contacts:
i.
The Afghan MoPH (specifically the General Directorate of
Administrative Affairs and General Directorate of Health Services Delivery)
will have a participatory role and will be involved in providing insight,
contacts and guidance for the assessment study
ii.
The CMS and identified public hospitals management will have a
participatory role and will be involved in providing insight, access to
necessary documents, employees and facilities
iii.
The CMS employees will participate by providing insight into
daily operations and will be involved in providing access to necessary documents
and facilities
iv.
The hospital employees, specifically those in the pharmacies,
will participate by providing insight into daily operations and will be involved
in providing access to necessary documents and facilities
v.
NGOs currently working in Kabul in pharmaceutical management who
can provide input on current situation
vi.
Other representatives as identified and required as the
assessment study progresses.
2.
Meetings:
Before, during, and after the assignment, the following meetings, phone calls,
communications and contact between the commissioning organization are planned:
a.
The assessment team will meet regularly to facilitate
communication and to ensure assessment information is being shared in an
appropriate and transparent manner. The purpose of the meetings is to facilitate
sharing of all research data collected and new contacts, updating the team on
assessment findings and ensuring the assessment study is on time and on track to
achieve the projected goals and outcomes.
b.
The assessment team will meet twice monthly with the HPIC staff
to maintain open communication and to ensure all deadlines will be met and that
all data is being collected and collated in an appropriate manner.
c.
All stakeholders, in addition to HPIC and assessment team, will
meet on an as needed basis to maintain open communication, to ensure all
deadlines will be met and to share appropriate information.
d.
At the end of the assessment, a meeting of all stakeholders will
be held to discuss the outcomes of the assessment and to work together to
identify the next steps in the process.
3.
Methods:
During the assignment, methods such as interviews, focus groups,
a desk review, field visits, etc. will be carried out. Assessment methods
include, but are not limited to:
a.
A thorough literature review to assess all research on the CMS,
public hospitals and pharmaceutical waste management in Afghanistan; looking at
both present and past formal and informal research as well as pertinent regional
studies. A summary of this research will be included in the final report.
b.
Interviews and/or discussion groups with key CMS and hospital
staff, CMS and hospital management, MoPH officials (General Directorate of
Administrative Affairs, General Directorate of Pharmaceutical Affairs and
General Directorate of Health Services Delivery), regional and international
environmental waste management and warehouse/logistics experts, local and/or
international non-governmental organizations and other organizations as deemed
necessary.
c.
Field visits to the CMS, identified public hospitals, waste
disposal sites, other pharmaceutical warehouses in Afghanistan and other
relevant establishments as necessary.
4.
Resources Available:
During the assignment, the evaluation team will have access to the following
resources as required:
a.
Access to HPIC staff
b.
Access to CMS and Identified Public Hospitals
c.
Current literature on CMS and hospital activities
d.
Transportation, lodging and insurance while in Afghanistan
e.
Office space while in Kabul (including use of a computer and
printer)
I.
SPECIFIC TASKS
Tasks:
a.
Preparation
i.
Literature review of existing information/documents
ii.
Develop assessment framework and tools
iii.
Harmonize and finalize assessment tools
b.
Conducting the assessment
i.
Identify key informants and contacts
ii.
Key informant interviews and group discussions
iii.
Conduct facility visits
iv.
Share preliminary findings with stakeholders
c.
Post assessment
i.
Compile data
ii.
Analyze data
iii.
Prepare preliminary report and recommendations
d.
Presentation and finalization
i.
Share preliminary report and recommendations with HPIC
ii.
Prepare final report and submit to HPIC
Was
this job of interest to you?
Receive 20-25 jobs & consultancies
in your email each day via
our 3 Months DevNetJobs Value Membership. For only USD 44 for 3 months.
Click here to
proceed
|